Hypoxia-mediated tumour targeting (Q44368762)

2 December 2017

title

Hypoxia-mediated tumour targeting (English)

1 reference

2 December 2017

0 references

K Binley

1

1 reference

2 December 2017

Z Askham

2

1 reference

2 December 2017

L Martin

3

1 reference

2 December 2017

H Spearman

4

1 reference

2 December 2017

D Day

5

1 reference

2 December 2017

S Kingsman

6

1 reference

2 December 2017

S Naylor

7

1 reference

2 December 2017

publication date

1 April 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

10

1 reference

2 December 2017

issue

7

1 reference

2 December 2017

page(s)

540-549

1 reference

Tissue-specific promoters in gene therapy for the treatment of prostate cancer

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

Inducible operation of the erythropoietin 3' enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

Characterization of physiologically regulated vectors for the treatment of ischemic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

The macrophage - a novel system to deliver gene therapy to pathological hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

Analysis of tissue-specific gene delivery by recombinant adenoviruses containing cardiac-specific promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

Modulation of the specificity and activity of a cellular promoter in an adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

Adenovirus-mediated transfer of bax with caspase-8 controlled by myelin basic protein promoter exerts an enhanced cytotoxic effect in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

Direct retroviral delivery of human cytochrome P450 2B6 for gene-directed enzyme prodrug therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

Cytochrome P450-based cancer gene therapy: recent advances and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

Characterization of the cyclooxygenase-2 promoter in an adenoviral vector and its application for the mitigation of toxicity in suicide gene therapy of gastrointestinal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

Toward a new generation of conditionally replicating adenoviruses: pairing tumor selectivity with maximal oncolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

Complementary adenoviral vectors for oncolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

Oxygen-sensitive enzyme-prodrug gene therapy for the eradication of radiation-resistant solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

Hypoxia-inducible regulation of a prodrug-activating enzyme for tumor-specific gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

A simplified system for generating recombinant adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301944

21 January 2018

Identifiers

DOI

10.1038/SJ.GT.3301944

1 reference

2 December 2017

1 reference